PPARγ Agonists: Emergent Therapy in Endometriosis.

Vallée A, Vallée JN, Le Blanche A, Lecarpentier Y

Open source

DOI
10.3390/ph14060543
Published
2021 Jun 6
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph14060543,
  title = {PPARγ Agonists: Emergent Therapy in Endometriosis.},
  author = {Vallée A and Vallée JN and Le Blanche A and Lecarpentier Y},
  year = {2021},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph14060543},
  url = {https://doi.org/10.3390/ph14060543}
}

RIS

TY  - JOUR
TI  - PPARγ Agonists: Emergent Therapy in Endometriosis.
AU  - Vallée A
AU  - Vallée JN
AU  - Le Blanche A
AU  - Lecarpentier Y
PY  - 2021
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph14060543
UR  - https://doi.org/10.3390/ph14060543
ER  - 

APA

A, V., JN, V., A, L. B., & Y, L. (2021). PPARγ Agonists: Emergent Therapy in Endometriosis.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph14060543

Source records